“Evidences of Safety and Tolerability of the Zoledronic Acid 5 Mg Yearly in the Post-Menopausal Osteoporosis: The HORIZON Project”. 2009. Reumatismo 61 (1): 54-64. https://doi.org/10.4081/reumatismo.2009.54.